Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
JFL Life Sciences IPO is a fixed price issue of ₹18.17 crores. The issue is entirely a fresh issue of 0.30 crore shares of ₹18.17 crore.
JFL Life Sciences IPO bidding started from Aug 25, 2022 and ended on Aug 30, 2022. The allotment for JFL Life Sciences IPO was finalized on Sep 5, 2022. The shares got listed on NSE SME on Sep 8, 2022.
JFL Life Sciences IPO price is ₹61.00 per share . The lot size for an application is 2,000. The minimum amount of investment required by an individual investor (retail) is ₹1,22,000 (2000 shares). The minimum lot size investment for HNI is 2 lots (4,000 shares), amounting to ₹2,44,000.
GYR Capital Advisors Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. The market maker of the company is Econo Broking Pvt.Ltd..
Refer to JFL Life Sciences IPO RHP for detailed Information.
| IPO Date | August 25, 2022 to August 30, 2022 |
| Listing Date | September 8, 2022 |
| Face Value | ₹10 per share |
| Issue Price Band | |
| Issue Price Final | ₹61 per share |
| Lot Size | 2,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 29,78,000 shares (aggregating up to ₹18.17 Cr) |
| Reserved for Market Maker | 1,50,000 shares Econo Broking Pvt.Ltd. (aggregating up to ₹0.9150 Cr) |
| Net Offered to Public | 28,28,000 shares (aggregating up to ₹17.25 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 80,20,441 shares |
| Share Holding Post Issue | 1,09,98,441 shares |
JFL Life Sciences IPO offers total 29,78,000 shares. Out of which 14,14,000 (47.48%) allocated to NII, 14,14,000 (47.48%) allocated to RII.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 1,50,000 (5.04%) |
| NII (HNI) Shares Offered | 14,14,000 (47.48%) |
| Retail Shares Offered | 14,14,000 (47.48%) |
| Total Shares Offered | 29,78,000 (100.00%) |
JFL Life Sciences IPO opens on August 25, 2022, and closes on August 30, 2022.
| IPO Open Date | Thu, Aug 25, 2022 |
| IPO Close Date | Tue, Aug 30, 2022 |
| Tentative Allotment | Mon, Sep 5, 2022 |
| Initiation of Refunds | Tue, Sep 6, 2022 |
| Credit of Shares to Demat | Wed, Sep 7, 2022 |
| Tentative Listing Date | Thu, Sep 8, 2022 |
| Cut-off time for UPI mandate confirmation | 5 PM on Tue, Aug 30, 2022 |
Investors can bid for a minimum of 2,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹1,22,000 |
| Retail (Max) | 1 | 2,000 | ₹1,22,000 |
| HNI (Min) | 2 | 4,000 | ₹2,44,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2010, JFL Life Sciences Limited is engaged in the business of manufacturing of pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).
The company's sales strategy is to sell the products in bulk to pharmaceutical marketers and traders who in turn provide the channel for sales to customers. JFL Life Sciences Limited has a market presence in PAN India and JFL's products are supplied to 10 developed and developing countries throughout the World.
JFL Life Sciences Limited exports products to African, Middle Eastern, and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing a particular product. Few of our products are also registered with Ukraine, Uzbekistan, and Kazakhstan (CIS countries) through merchants.
JFL has two manufacturing units (on lease) in Gujarat.
Competitive Strength :
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus |
|---|---|---|---|---|---|
| 31-Aug-19 | 1614.96 | 3177.96 | 30.25 | 501.49 | 459.2 |
| 31-Mar-20 | 2432.59 | 3020.41 | 36.04 | 537.53 | 495.24 |
| 31-Mar-21 | 2900.69 | 3286.89 | 54.21 | 687.25 | 637.55 |
| 28-Feb-22 | 3662.86 | 2563.06 | 253.28 | 1096.52 | 294.48 |
| Amount in ₹ Lakhs | |||||
The market capitalization of JFL Life Sciences IPO is ₹67.09 Cr.
| Pre IPO | Post IPO | |
|---|---|---|
| P/E (x) | 26.52 |
The Company proposes to utilize the funds which are being raised through this Issue ("Net Proceeds") towards the following objects:
[Dilip Davda] The company is in the pharma sector and has already created an extra facility for its product lines and has the necessary certifications in hand for global markets. Due to the pandemic and the thrust for expansion, it posted static top lines but managed to get higher margins for certain products. It is now ready with additional capacities to reap the benefits of demand. Considering fancy for pharma sector counters, investors may consider an investment with a medium to long-term perspective in this fully priced issue. Read detail review...
| Listing Date | September 8, 2022 |
| BSE Script Code | |
| NSE Symbol | JFLLIFE |
| ISIN | INE0LA901015 |
| Final Issue Price | ₹61 per share |
| BSE Listing Group | ST |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹61.00 |
| Open | ₹70.00 |
| Low | ₹66.50 |
| High | ₹70.00 |
| Last Trade | ₹66.50 |
JFL Life Sciences Ltd.
309, Satyam Mall,
Opp. Saman Complex, Nr. Vishweshwar Mahadev Mandir
Settelite
Ahmedabad, Gujarat, 380015
Phone: 937729 5575
Email: cs@jfllifesciences.com
Website: http://www.jfllifesciences.com/
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: jfl.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
JFL Life Sciences IPO is a SME IPO of 29,78,000 equity shares of the face value of ₹10 aggregating up to ₹18.17 Crores. The issue is priced at ₹61 per share. The minimum order quantity is 2000.
The IPO opens on August 25, 2022, and closes on August 30, 2022.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in JFL Life Sciences IPO using UPI as a payment gateway. Zerodha customers can apply in JFL Life Sciences IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in JFL Life Sciences IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The JFL Life Sciences IPO opens on August 25, 2022 and closes on August 30, 2022.
JFL Life Sciences IPO lot size is 2000, and the minimum amount required for application is ₹1,22,000.
You can apply in JFL Life Sciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for JFL Life Sciences IPO will be done on Monday, September 5, 2022, and the allotted shares will be credited to your demat account by Wednesday, September 7, 2022. Check the JFL Life Sciences IPO allotment status.
The JFL Life Sciences IPO listing date is on Thursday, September 8, 2022.
Useful Articles
RHP